Nadine Kronfli receives 2021 AMMI Canada New Investigator Award
RI-MUHC researcher confronts the unique challenges of eliminating infectious diseases in prisons
Benefits of fluvoxamine confirmed in new study
Preventing hospitalization following COVID-19 infection in vulnerable populations
TB and COVID-19, a joint battle?
On World TB Day 2022, we are looking at how researchers from the McGill International TB Centre at the RI-MUHC are working to raise awareness and to put an end to TB.
Cecilia Costiniuk receives 2022 CAHR-CANFAR Excellence in Research Award
RI-MUHC researcher is committed to improving the lives of those living with HIV
Spotlight paper in World Journal of Hepatology: Alshaima Al Hinai
Recognition for former RI-MUHC trainee’s work on nonalcoholic fatty liver disease
COVID-19: A close look at vaccine strategies used with older people in Quebec
A new study determines the maximum recommended interval between the first and second doses of mRNA...
CTN study tests new drug for the first time in people living with HIV
Postdoc Léna Royston aims to understand how cytomegalovirus infection can increase inflammation and cause health issues
Fall 2021 CIHR competition results
RI-MUHC teams received $9.5 million in project funding
Marcel Behr appointed interim director McGill Interdisciplinary Initiative in Infection and Immunity
Founding director Don Sheppard to direct Antimicrobial Resistance Task Force at the Public Health Agency...
A clear picture of the cost and efficacy of COVID-19 outpatient treatments
In a new study, RI-MUHC researchers have assessed all available outpatient therapies for COVID-19 to facilitate...